πŸ‡ΊπŸ‡Έ FDA
Patent

US 11925679

H3.3 CTL peptides and uses thereof

granted A61KA61K2039/80A61K2239/31

Quick answer

US patent 11925679 (H3.3 CTL peptides and uses thereof) held by The Regents of the University of California expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/80, A61K2239/31, A61K2239/38, A61K2239/47